Intrinsic tumour suppression

被引:1031
作者
Lowe, SW
Cepero, E
Evan, G
机构
[1] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA
[2] Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA
关键词
D O I
10.1038/nature03098
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Mutations that drive uncontrolled cell-cycle progression are requisite events in tumorigenesis. But evolution has installed in the proliferative programmes of mammalian cells a variety of innate tumour-suppressive mechanisms that trigger apoptosis or senescence, should proliferation become aberrant. These contingent processes rely on a series of sensors and transducers that act in a coordinated network to target the machinery responsible for apoptosis and cell-cycle arrest at different points. Although oncogenic mutations that disable such networks can have profound and varied effects on tumour evolution, they may leave intact latent tumour-suppressive potential that can be harnessed therapeutically.
引用
收藏
页码:307 / 315
页数:9
相关论文
共 99 条
[1]  
ASKEW DS, 1991, ONCOGENE, V6, P1915
[2]   Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics [J].
Aslanian, A ;
Iaquinta, PJ ;
Verona, R ;
Lees, JA .
GENES & DEVELOPMENT, 2004, 18 (12) :1413-1422
[3]   Myc-mediated proliferation and lymphomagenesis, but not apoptosis, are compromised by E2F1 loss [J].
Baudino, TA ;
Maclean, KH ;
Brennan, J ;
Parganas, E ;
Yang, CY ;
Aslanian, A ;
Lees, JA ;
Sherr, CJ ;
Roussel, MF ;
Cleveland, JL .
MOLECULAR CELL, 2003, 11 (04) :905-914
[4]   Normal human fibroblasts are resistant to RAS-induced senescence [J].
Benanti, JA ;
Galloway, DA .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (07) :2842-2852
[5]   p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis [J].
Bergamaschi, D ;
Gasco, M ;
Hiller, L ;
Sullivan, A ;
Syed, N ;
Trigiante, G ;
Yulug, I ;
Merlano, M ;
Numico, G ;
Comino, A ;
Attard, M ;
Reelfs, O ;
Gusterson, B ;
Bell, AK ;
Heath, V ;
Tavassoli, M ;
Farrell, PJ ;
Smith, P ;
Lu, X ;
Crook, T .
CANCER CELL, 2003, 3 (04) :387-402
[6]   Novel cancer therapy by reactivation of the p53 apoptosis pathway [J].
Bykov, VJN ;
Wiman, KG .
ANNALS OF MEDICINE, 2003, 35 (07) :458-465
[7]   Cellular senescence as a tumor-suppressor mechanism [J].
Campisi, J .
TRENDS IN CELL BIOLOGY, 2001, 11 (11) :S27-S31
[8]   Essential role for oncogenic Ras in tumour maintenance [J].
Chin, L ;
Tam, A ;
Pomerantz, J ;
Wong, M ;
Holash, J ;
Bardeesy, N ;
Shen, Q ;
O'Hagan, R ;
Pantginis, J ;
Zhou, H ;
Horner, JW ;
Cordon-Cardo, C ;
Yancopoulos, GD ;
DePinho, RA .
NATURE, 1999, 400 (6743) :468-472
[9]   A 2ND SIGNAL SUPPLIED BY INSULIN-LIKE GROWTH-FACTOR-II IN ONCOGENE-INDUCED TUMORIGENESIS [J].
CHRISTOFORI, G ;
NAIK, P ;
HANAHAN, D .
NATURE, 1994, 369 (6479) :414-418
[10]   The DNA damage checkpoint in embryonic cell cycles is dependent on the DNA-to-cytoplasmic ratio [J].
Conn, CW ;
Lewellyn, AL ;
Maller, JL .
DEVELOPMENTAL CELL, 2004, 7 (02) :275-281